Loading…

WAVELINE‐004: OPEN‐LABEL, PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (MK‐2140) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2023-06, Vol.41 (S2), p.208-209
Main Authors:	Fosså, A., Ozcan, M., Song, Y., Lee, S. T., Mensah, F., Modi, D., Kim, W. S., Paszkiewicz‐Kozik, E., Sawalha, Y., Sevindik, O. G., Norasetthada, L., Santoro, A., Pathiraja, K., Chakraborty, S., Marinello, P., Lavie, D.
Format:	Article
Language:	English
Subjects:	Lymphoma
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!